Showing results (631-640 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|December 4, 2010
Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V LeidenNikos Eleftheriadis, Pantelis MakrisTherapeutics and Clinical Risk Management|December 4, 2010
New advances in the treatment of gout: review of pegloticaseMattheus K Reinders, Tim L Th A JansenTherapeutics and Clinical Risk Management|June 8, 2010
Obesity is not associated with contrast nephropathyNavin Jaipaul, Rendell Manalo, Seyed-Ali Sadjadi, et al.Therapeutics and Clinical Risk Management|June 8, 2010
Serum glutathione transferase does not respond to indole-3-carbinol: A pilot studyDaniel R McGrath, Hamid Frydoonfar, Joshua J Hunt, et al.Therapeutics and Clinical Risk Management|June 8, 2010
Maximum opening of the mouth by mouth prop during dental procedures increases the risk of upper airway constrictionHiroshi Ito, Hiroyoshi Kawaai, Shinya Yamazaki, et al.Therapeutics and Clinical Risk Management|July 30, 2010
Analysis of factors influencing the overall effect of racecadotril on childhood acute diarrhea. Results from a real-world and post-authorization surveillance study in VenezuelaJose ChacónTherapeutics and Clinical Risk Management|September 22, 2010
Molecular mechanisms and treatment strategies for Dupuytren's diseaseDavid B O'Gorman, Linda Vi, Bing Siang GanTherapeutics and Clinical Risk Management|September 22, 2010
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tabletsClaudio Gasperini, Serena Ruggieri, Carlo PozzilliTherapeutics and Clinical Risk Management|July 3, 2010
Management of ANCA-associated vasculitis: Current trends and future prospectsSally Hamour, Alan D Salama, Charles D PuseyTherapeutics and Clinical Risk Management|July 3, 2010
Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reductionRavi Vachhani, Doumit Bouhaidar, Alvin Zfass, et al.Pageof 256